Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
Condition:   Atypical Endometrial Hyperplasia Interventions:   Drug: Megestrol Acetate;   Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsors:   Fudan University;   Shanghai 6th People's Hospital;   Zhejiang Cancer Hospital;   Shanghai Changning Maternity& Infant Health Hospital Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Condition:   Endometrial Neoplasm Malignant Stage I Interventions:   Drug: Megestrol Acetate;   Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsor:   Fudan University Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
Condition:   Atypical Endometrial Hyperplasia Interventions:   Drug: Megestrol Acetate;   Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsors:   Fudan University;   Shanghai 6th People's Hospital;   Zhejiang Cancer Hospital;   Shanghai Changning Maternity& Infant Health Hospital Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Condition:   Endometrial Neoplasm Malignant Stage I Interventions:   Drug: Megestrol Acetate;   Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsor:   Fudan University Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials